711 related articles for article (PubMed ID: 8627558)
1. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
DeBoer P; Abercrombie ED
J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
[TBL] [Abstract][Full Text] [Related]
2. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.
Acquas E; Wilson C; Fibiger HC
J Pharmacol Exp Ther; 1997 Apr; 281(1):360-8. PubMed ID: 9103518
[TBL] [Abstract][Full Text] [Related]
3. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
Damsma G; Robertson GS; Tham CS; Fibiger HC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
[TBL] [Abstract][Full Text] [Related]
5. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
Imperato A; Obinu MC; Casu MA; Mascia MS; Dazzi L; Gessa GL
J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643
[TBL] [Abstract][Full Text] [Related]
6. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
7. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
8. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
9. Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum.
Zackheim J; Abercrombie ED
Neuroscience; 2005; 131(2):423-36. PubMed ID: 15708484
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition.
Acquas E; Fibiger HC
J Neurochem; 1998 Mar; 70(3):1088-93. PubMed ID: 9489729
[TBL] [Abstract][Full Text] [Related]
11. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
[TBL] [Abstract][Full Text] [Related]
12. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie ED; DeBoer P
J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
[TBL] [Abstract][Full Text] [Related]
13. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
Jin S; Johansson B; Fredholm BB
J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
Napier TC; Maslowski-Cobuzzi RJ
Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
[TBL] [Abstract][Full Text] [Related]
15. Intracellularly recorded response of rat striatal neurons in vitro to fenoldopam and SKF 38393 following lesions of midbrain dopamine cells.
Twery MJ; Thompson LA; Walters JR
Synapse; 1994 Sep; 18(1):67-78. PubMed ID: 7825125
[TBL] [Abstract][Full Text] [Related]
16. Is in vivo striatal acetylcholine output under a tonic inhibitory control by dopamine?
Imperato A; Obinu MC; Gessa GL
J Neural Transm Suppl; 1995; 45():91-102. PubMed ID: 8748614
[TBL] [Abstract][Full Text] [Related]
17. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
Byrnes EM; Bruno JP
Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
Huang KX; Walters JR
J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
[TBL] [Abstract][Full Text] [Related]
19. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
Calabresi P; Mercuri NB; Sancesario G; Bernardi G
Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
